儿童原发纵隔大B细胞淋巴瘤细胞因子浓度与疾病范围及结局相关
该研究在62例儿童原发纵隔大B细胞淋巴瘤(PMBCL)患者中检测诊断时24种血浆细胞因子浓度,发现CCL4、CCL17、IL-6、CXCL8、CXCL9、CXCL10和CXCL11升高。CCL17、CXCL9和CXCL10与纵隔肿瘤体积(MTV)和乳酸脱氢酶(LDH)相关,而IL-6、IL-10、IL-17A和IL-22与较差的无事件生存(EFS)相关。
要点
- 儿童PMBCL诊断时CCL17、CXCL9、CXCL10与肿瘤负荷相关。
- IL-6、IL-10、IL-17A、IL-22升高与较差EFS相关。
- IL-6与结局关联最强(HR 6.8,95%CI 1.5-30.9)。
核心结论
- 儿童PMBCL治疗前细胞因子水平呈现与肿瘤负荷(CCL17、CXCL9、CXCL10)和结局(IL-6、IL-10、IL-17A、IL-22)相关的不同模式。
研究设计与样本
- 基于人群的儿童PMBCL队列,62例患者诊断时检测24种血浆细胞因子。
- 对照组为26例年龄匹配的其他类型淋巴瘤长期缓解患者及健康个体。
主要发现
- 与对照组相比,PMBCL患者CCL4、CCL17、IL-6、CXCL8、CXCL9、CXCL10和CXCL11浓度升高。
- PMBCL患者CCL17中位水平为1695 pg/ml(IQR 642-3142),对照组为81 pg/ml(IQR 41-190),p < 0.0001。
- CCL17、CXCL9和CXCL10浓度与MTV和LDH显著相关,但与EFS无关。
- IL-17F和IL-22浓度与LDH和MTV呈负相关。
- 在50例接受剂量调整EPOCH联合利妥昔单抗统一治疗的患者亚组中,IL-6、IL-10、IL-17A和IL-22升高与较差EFS显著相关。
关键数值与推荐
- IL-6与结局关联最强,风险比6.8(95%CI 1.5-30.9)。
临床怎么用
- 治疗前细胞因子谱可能有助于评估儿童PMBCL肿瘤负荷和预后分层。
局限性
- 结局分析基于有限的事件数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary mediastinal large B-cell lymphoma (PMBCL) predominantly affects female adolescents and young adults. It displays an immune-privileged phenotype and demonstrates the involvement of key cytokine signaling pathways, including increased expression of Thymus and activation-regulated chemokine (TARC/CCL17). Currently, there is a lack of established markers for stratification. We studied plasma concentrations of 24 cytokines at diagnosis in a large population-based pediatric cohort of 62 patients with PMBCL. Compared to a group of age-matched patients with other types of lymphoma in long-term remission and healthy individuals (n=26), we detected elevated concentrations of CCL4, CCL17, interleukin (IL)-6, CXCL8, CXCL9, CXCL10, and CXCL11. The median CCL17 level was 1695 pg/ml (IQR, 642-3142) in patients with PMBCL compared to 81 pg/ml (IQR, 41-190) in controls (p < 0.0001). Concentrations of CCL17, CXCL9, and CXCL10 significantly correlated with mediastinal tumor volume (MTV) and lactate dehydrogenase activity (LDH) but were not associated with event-free survival (EFS). Concentrations of IL-17F and IL-22 were inversely correlated with LDH and MTV. Elevated IL-6, IL-10, IL-17A, and IL-22 were significantly correlated with inferior EFS in a subgroup of 50 patients uniformly treated with dose-adjusted EPOCH with rituximab. Although based on a limited number of events, IL-6 showed the strongest association with outcome (hazard ratio of 6.8 (95%-CI, 1.5-30.9). In summary, pretreatment cytokine levels in patients with PMBCL reveal distinct patterns associated with tumor burden (CCL17, CXCL9, CXCL10) and outcome (IL-6, IL-10, IL-17A, IL-22).
引用
- Nipper M, Damm-Welk C, Shepheard W, et al. Cytokine concentrations in pediatric primary mediastinal large B cell lymphoma correlate with disease extent and outcome. Blood Adv. 2026. PMID: 42721456. doi:10.1182/bloodadvances.2026021463
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。